Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 More is better.

× No keyword cloud information.

13 in total

1. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.

Authors: Douglas R Strother; Lucie Lafay-Cousin; James M Boyett; Peter Burger; Patricia Aronin; Louis Constine; Patricia Duffner; Mehmet Kocak; Larry E Kun; Marc E Horowitz; Amar Gajjar
Journal: Neuro Oncol Date: 2013-12-12 Impact factor: 12.300

Review 2. Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review.

Authors: Milly E de Jonge; Alwin D R Huitema; Jan H M Schellens; Sjoerd Rodenhuis; Jos H Beijnen
Journal: Clin Pharmacokinet Date: 2005 Impact factor: 6.447

Review 3. Maximum tolerated dose: clinical endpoint for a bygone era?

Authors: Chris H Takimoto
Journal: Target Oncol Date: 2009-04-18 Impact factor: 4.493

4. Difficulties defining the role of high-dose chemotherapy in the management of breast cancer.

Authors: M Markman
Journal: J Cancer Res Clin Oncol Date: 1995 Impact factor: 4.553

5. Compliance of physicians and patients with a consensus protocol for treatment of advanced breast cancer.

Authors: F Porzsolt; G Meuret; E D Kreuser; S Mende; L Buchelt; P Strigl; M Redenbacher; F Klumpp; M Schmelz; R Knöchelmann
Journal: J Cancer Res Clin Oncol Date: 1989 Impact factor: 4.553

6. Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat model.

Authors: Minghan Shi; David Fortin; Léon Sanche; Benoit Paquette
Journal: Invest New Drugs Date: 2015-03-18 Impact factor: 3.850

More is better.

1. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.

Review 2. Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review.

Review 3. Maximum tolerated dose: clinical endpoint for a bygone era?

4. Difficulties defining the role of high-dose chemotherapy in the management of breast cancer.

5. Compliance of physicians and patients with a consensus protocol for treatment of advanced breast cancer.

6. Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat model.

7. Dose-intensive treatment of breast cancer supported by granulocyte-macrophage colony-stimulating factor (GM-CSF).

Review 8. Experimental and clinical studies alternating chemotherapy and radiotherapy.

Review 9. Pharmacokinetic optimisation of anticancer therapy.

10. Modeling NSCLC progression: recent advances and opportunities available.